During the past decade, Gemeinschaftsklinikum Mittelrhein gGmbH conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gemeinschaftsklinikum Mittelrhein gGmbH" #1 sponsor was "Technische Universität Dresden" with 2 trials, followed by "Universitätsklinikum Hamburg-Eppendorf" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Articulinx" with 1 trials sponsored and "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gemeinschaftsklinikum Mittelrhein gGmbH" #1 collaborator was "Deutsche Kinderkrebsstiftung" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Hannover Medical School" with 1 trials as a collaborator, "Masaryk University" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Gemeinschaftsklinikum Mittelrhein gGmbH" are "AML" (1 trials), "Acute Myeloid Leukemia" (1 trials), "Anaplastic Astrocytoma WHO Grade III" (1 trials), "B-Precursor ALL" (1 trials) and "Brain Tumors" (1 trials). Many other conditions were trialed in "Gemeinschaftsklinikum Mittelrhein gGmbH" in a lesser frequency.

Most popular intervention types in "Gemeinschaftsklinikum Mittelrhein gGmbH" are "Drug" (9 trials), "Device" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABSORB Scaffold" (1 trials), "Azacitidine" (1 trials), "Bempedoic acid and/or its fixed-dose combination with ezetimibe" (1 trials), "Blinatumomab" (1 trials) and "CPX-351" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gemeinschaftsklinikum Mittelrhein gGmbH" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Gemeinschaftsklinikum Mittelrhein gGmbH". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Gemeinschaftsklinikum Mittelrhein gGmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gemeinschaftsklinikum Mittelrhein gGmbH, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Gemeinschaftsklinikum Mittelrhein gGmbH has several departments that took part in Clinical trials: "Gemeinschaftsklinikum Mittelrhein Kemperhof, Klinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie und Onkologie" - 2 trials